Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin)

Author： Ouchi Masaaki   Kawamura Hitoshi   Urata Yasuo   Fujiwara Toshiyoshi  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.27, Iss.3, 2009-06, pp. : 241-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter

By  

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Synergistic Interaction of Telomerase-Specific Oncolytic Virotherapy and Chemotherapeutic Agents for Human Cancer

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1809-1816

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic adenovirus research and applications

By Kangasniemi Lotta   Hemminki Akseli  

Future Virology, Vol. 5, Iss. 6, 2010-11 ,pp. : 745-761

Future Medicine

Access to resources Recommend Favorite

Biodistribution and Safety Assessment of Bladder Cancer Specific Recombinant Oncolytic Adenovirus in Subcutaneous Xenografts Tumor Model in Nude Mice

By  

Current Gene Therapy, Vol. 12, Iss. 2, 2012-04 ,pp. : 67-76

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies of Development of Antiviral Agents Directed Against Influenza Virus Replication

By  

Current Pharmaceutical Design, Vol. 13, Iss. 34, 2007-12 ,pp. : 3531-3542

Bentham Science Publishers

Access to resources Recommend Favorite